DonDonDonDon Wednesday, 05/05/21 12:13:33 AM Re: Rockleo post# 163516 Post # of 164279 Quote:ACTIV-1 IM (Immune Modulators) was launched with much fanfare in Oct 2020. It was to enroll approximately 2000 patients over a 6 month period. ie April 2021. Infliximab / Abatacept / Cenicriviroc were selected as the GAME CHANGERS. Being run as an ADAPTIVE STUDY, they know EXACTLY how each drug is doing ..and have the power to change Endpoints with impunity. Why have we not heard the BRILLIANT RESULTS SO FAR..?? BECAUSE.. There is only one LERONLIMAB. You haven't heard anything about the results of the ACTIV-1 trial because it is still in progress. The fact that the government sees the data as it comes in doesn't mean they announce the results as they come in. I'm surprised this needs explaining.